Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Obesity and bariatric surgery can cause hair thinning and temporary hair loss due to nutritional deficiencies and stress.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.

Cyclosporin doesn't stop hair loss.

Terbinafine can cause hair loss.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Acute illnesses like sepsis can disrupt thyroid hormone balance without central hypothyroidism.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Dystonia may be part of PAS-4 and linked to immune issues.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Infliximab may cause hair loss in Crohn's disease patients.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Managing multiple autoimmune diseases in one patient is very challenging.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.